Healthpeak–Janus Living Announce $840M IPO
Healthpeak Properties, Inc. and Janus Living, Inc. have officially announced the pricing of Janus Living’s upsized initial public offering (IPO), marking a significant milestone for both organizations and the broader real estate investment sector. The offering consists of 42,000,000 shares of Janus Living Class A-1 common stock, priced at $20.00 per share, reflecting strong investor interest and confidence in the company’s growth strategy.
The IPO has been structured to include an additional provision that allows underwriters to purchase up to 6,300,000 extra shares within a 30-day window. This option, commonly referred to as a “greenshoe” option, is priced at the same initial offering rate, minus underwriting discounts. Such provisions are often included in large-scale public offerings to accommodate excess demand and stabilize the stock price during the early stages of trading.
Janus Living’s Class A-1 common stock is expected to begin trading on the New York Stock Exchange under the ticker symbol “JAN” on March 20, 2026. The IPO is anticipated to close on March 23, 2026, subject to standard closing conditions. The listing on one of the world’s most prominent stock exchanges represents a major step forward for Janus Living as it transitions into a publicly traded entity, increasing its visibility among global investors and expanding access to capital markets.
The company has outlined clear plans for the utilization of the proceeds generated from the offering. Janus Living intends to deploy the net funds toward strategic acquisitions and investments that align with its defined criteria. These may include opportunities within the real estate and housing sectors that promise long-term value creation. In addition to acquisitions, a portion of the proceeds will be allocated for general corporate purposes, ensuring operational flexibility and supporting ongoing business initiatives.
Following the completion of the IPO, Healthpeak will maintain a substantial ownership stake in Janus Living. Specifically, Healthpeak is expected to hold approximately 214,734,000 shares of Janus Living’s common stock. This translates to an estimated 83.6% voting interest in the company, or 81.6% if the underwriters exercise their option to purchase additional shares in full. This level of ownership ensures that Healthpeak will continue to play a dominant role in shaping Janus Living’s strategic direction and governance, even as the company enters the public market.
The IPO has attracted the involvement of several major financial institutions, underscoring its scale and importance. BofA Securities and J.P. Morgan are serving as lead book-running managers for the offering, coordinating the overall process and managing investor demand. Additional bookrunners include prominent firms such as Wells Fargo Securities, Barclays, Goldman Sachs & Co. LLC, RBC Capital Markets, and Morgan Stanley.
A broader syndicate of financial institutions is also supporting the offering as senior co-managers, including BNP Paribas, Crédit Agricole CIB, KeyBanc Capital Markets, PNC Capital Markets LLC, Scotiabank, TD Securities, and Truist Securities. Additionally, several firms are participating as co-managers, contributing to the distribution and marketing of the offering across various investor segments.
The offering is being conducted exclusively through a formal prospectus, which provides detailed information about Janus Living’s business model, financial performance, and risk factors. Interested investors can obtain copies of the final prospectus through the designated channels provided by the lead underwriters. These documents are essential for making informed investment decisions, as they outline the terms and conditions of the offering in full.
The IPO has been registered with the U.S. Securities and Exchange Commission (SEC) through a Form S-11 registration statement, which has been declared effective. This regulatory approval confirms that the offering complies with applicable securities laws and disclosure requirements in the United States. However, it is important to note that this announcement does not constitute an offer to sell or a solicitation to buy securities in any jurisdiction where such activities would be considered unlawful prior to proper registration or qualification.
Overall, the successful pricing of Janus Living’s IPO highlights strong market demand and positions the company for its next phase of growth. Backed by Healthpeak’s significant ownership and supported by a robust network of financial institutions, Janus Living is poised to capitalize on new investment opportunities and expand its footprint in the real estate sector. The transition to a publicly traded company not only enhances its financial flexibility but also strengthens its ability to pursue long-term strategic objectives in an increasingly competitive market.
Source Link:https://www.businesswire.com/
